ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Exploring the Mechanism through which Phyllanthus emblica L. Extract Exerts Protective Effects against Acute Gouty Arthritis: A Network Pharmacology Study and Experimental Validation

Tao, Haolin; Zhong, Jingbin; Mo, Yingshi; Liu, Wenbin; Wang, Hui*广东药学院
Evidence-based Complementary and Alternative Medicine2022-4-11DOI: 10.1155/2022/9748338
1被引12阅读
引用收藏
分享

摘要

Increased uric acid levels and inflammatory reactions are the main factors considered responsible for the development of gouty arthritis. Phyllanthus emblica L. (PEL) has several promising pharmacological properties, including anti-inflammation and antioxidation. However, only a few studies have investigated its use for treating acute gouty arthritis (AGA), and the mechanism of action of PEL has not yet been clarified. The aim of this study was to verify the protective effects of PEL against gout and explore its underlying mechanism through network pharmacology and animal experiments. The main active components of the extract from PEL including mucic acid, mucic acid lactone, gallic acid, ethyl hexyl phthalate, and glucose were identified by UPLC-ESI-qTOF-MS. Network pharmacological analysis results revealed 13 active compounds in PEL and 85 related targets for the treatment of gout. The core mechanism of action of PEL is mainly associated with inflammation-related pathways, including the HIF-1, PI3K-Akt, TNF, and NOD-like receptor signaling pathways. Previous studies revealed that the NOD-like receptor signaling pathway, especially the NLRP3 inflammasome, plays an important role in the pathogenesis of AGA; therefore, we mainly investigated the effect of PEL on the NLRP3/ASC/caspase-1 pathway in gout rats. In the animal experiments, PEL was shown to have a satisfactory antigout effect, as it effectively reduced uric acid (UA) and xanthine oxidase (XOD) levels. In terms of inhibiting AGA-associated inflammatory reactions, our results showed that PEL significantly decreased the expression of NLRP3 and caspase-1 in ankle synoviocytes as well as the levels of downstream inflammatory factors, such as TNF-alpha, IL-10, and IL-1 beta in serum. Moreover, the results of our study show that PEL reduced MMP13 expression in the ankle synovium. Overall, the results of this study indicate that PEL exerted a therapeutic effect against AGA. Reducing uric acid levels, inhibiting inflammation, and decreasing the expression of MMP13 may be responsible for the therapeutic effect of PEL, which suggests that PEL can be further developed as a drug for the treatment of gout.

学科与关键词

关键词
NLRP3 INFLAMMASOMEFRUIT EXTRACTSCASPASE-1HYPERURICEMIAEPIDEMIOLOGYACTIVATIONRESOLUTIONPREDICTIONRELEASENALP3
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-04-11
卷期
第 2022 卷
页码
9748338
DOI
10.1155/2022/9748338
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Foundation for the Rural Science and Technology Correspondent of Guangdong Province [KTP20200178]

作者

  • T

    Tao, Haolin (第一作者)

    guangdong pharmaceut univ

  • Z

    Zhong, Jingbin

    guangdong pharmaceut univ

查看全部 5 位作者收起作者
  • M

    Mo, Yingshi

    guangdong pharmaceut univ

  • L

    Liu, Wenbin

    guangdong pharmaceut univ

  • W

    Wang, Hui (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417